Loading the research desk…

Lipocine Inc. (LPCN)

Publicly reported company facts and saved market data for Lipocine Inc. (LPCN), with sources and as-of times. Saved data is not a live quote.

Company profile

Lipocine is a biopharmaceutical company developing oral therapeutics using its proprietary drug-delivery technology platform. The Company advances product candidates addressing significant unmet medical needs and explores partnerships to support their development and commercialization.

Company facts

Sector
Health Care
Industry
Pharmaceutical Preparations
Market cap
$13.4M
Incorporated in
United States
Company website
www.lipocine.com
Exchange
NASDAQ

FennEdge notes

Sessions where LPCN appeared in the daily small-cap recap, newest first: opening gap, day change and the SEC filing or halt stored by the close. Facts with source links.

All daily recaps

Saved quote

Saved snapshot, not a real-time quote. Check the market time before relying on it.

Last reported price
$1.6415
Reported change
+1.33%
Reported volume
374,242
Latest market time

Short interest

Reported short interest
99,444 shares
Settlement date
Source
Nasdaq

Exchange-published short interest for the stated settlement date, not a live short position.

Recent daily sessions

The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.

LPCN daily open, high, low, close and volume
DateOpenHighLowCloseVolume
2.052.051.891.932,322,263
2.953.152.072.20105,835,900
2.082.102.072.1012,778
2.072.132.072.0719,764
2.082.132.052.0538,941
2.192.192.072.0771,207
2.142.252.082.2031,369
2.092.212.092.1624,256
2.072.212.062.0934,438
2.122.182.062.1032,766

Research this company

FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.

Sign in to continue